Research workbench
8EI3: Crystal structure of VHL in complex with H313, a Helicon Polypeptide
Analyse 8EI3: Crystal structure of VHL in complex with H313, a Helicon Polypeptide in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.
- PDB
- 8EI3
- Type
- protein
- Length
- 709 residues
- Chains
- 7
- Method
- x-ray diffraction
- Authors
- Li, K., Tokareva, O.S., Thomson, T.M., Verdine, G.L., McGee, J.H.
- Deposited
- 09/14/22
- Collection
- MolNFT v2 / PDB Bank
- Contract
- 0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
- Owner
- 0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
- Resolution
- 3.49
- Source
- Homo sapiens; SYNTHETIC CONSTRUCT
- Molecule
- Elongin-B; Elongin-C; von Hippel-Lindau disease tumor suppressor; H313
- UniProt
- Q15370, Q15369, P40337
- Ligands
- WHL
- Pockets
- 5 · best druggability 0.68
Structure
x-ray diffraction · resolution 3.49 · 6 distinct chains · 29% helix, 28% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Elongin-B | protein | 108 | 18% helix, 36% strand | Q15370 |
| B, E | Elongin-C | protein | 88 | 47% helix, 15% strand | Q15369 |
| C | von Hippel-Lindau disease tumor suppressor | protein | 151 | 26% helix, 28% strand | P40337 |
| D | Elongin-B | protein | 105 | 20% helix, 35% strand | Q15370 |
| F | von Hippel-Lindau disease tumor suppressor | protein | 152 | 28% helix, 27% strand | P40337 |
| G | H313 | protein | 17 | 76% helix, 0% strand | — |
Ligands and binding sites
- WHL · N,N'-(1,4-phenylene)diacetamide · ligand · chains C, G
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 873 | 0.68 | 0.74 | 83 | empty |
| 2 | 241 | 0.56 | 0.78 | 40 | empty |
| 3 | 147 | 0.42 | 0.75 | 21 | empty |
| 4 | 53 | 0.30 | 0.76 | 14 | empty |
| 5 | 51 | 0.28 | 0.75 | 18 | empty |
Interfaces
8 interfaces between chains.
- D–E · 1165 Ų buried · 14 hydrogen bonds · protein-protein
- A–B · 1117 Ų buried · 14 hydrogen bonds · protein-protein
- B–C · 1050 Ų buried · 15 hydrogen bonds · protein-protein
- E–F · 1012 Ų buried · 14 hydrogen bonds · protein-protein
- C–G · 598 Ų buried · 2 hydrogen bonds · protein-protein
Modifications
Observed in the structure: 2 covalent (covalent ligand).
Compared structures
- Q15370 · AlphaFold monomer V2.0 prediction for elongin-B (Q15370) · a predicted model of the same protein · chain D against A, TM-score 0.98
- P40337 · AlphaFold monomer V2.0 prediction for von hippel-lindau disease tumor suppressor (P40337) · a predicted model of the same protein · chain F against A, TM-score 0.98
- Q15369 · AlphaFold monomer V2.0 prediction for elongin-C (Q15369) · a predicted model of the same protein · chain B against A, TM-score 0.98
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q15370
- Every structure of UniProt Q15369
- Every structure of UniProt P40337
- Elsewhere: RCSB PDB 8EI3 · PDBe 8EI3 · UniProt Q15370 · UniProt Q15369 · UniProt P40337
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.